Atlas Trials

A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient

Clinical trial NCT03114618 · COMPLETED

Trial details

NCT number
NCT03114618
Sponsor
Andres muñoz
Status
COMPLETED
Study type
OBSERVATIONAL
Cancer-associated ThrombosisGenetic Predisposition
Start date
2013-03-01
Primary completion
2020-12-01
Enrollment
416

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.